Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period
Loupi, E.; Saliou, P.; Blangy, H.; Loeuille, D.; Gillet, P.; Debois, H.
2001

Abstract

Objectives: Intravesical BCG therapy remains the first-line prophylactic treatment for recurrences of superficial bladder tumours. However necessary the safety, of this medicinal product, for which a potential risk of complications was demonstrated during development, needs to be evaluated.

Details

Title Evaluation of the safety of intravesical BCG therapy in France: analysis of serious adverse events notified over a three-year period
Author(s) Loupi, E. ; Saliou, P. ; Blangy, H. ; Loeuille, D. ; Gillet, P. ; Debois, H.
Published in Progres En Urologie
Volume 11
Pages 458-465
Date 2001
Keywords
Other identifier(s) View record in Web of Science
Laboratories EPSL
Record Appears in Scientific production and competences > SB - School of Basic Sciences > IPHYS - Institute of Physics > EPSL - Earth and Planetary Science Laboratory
Peer-reviewed publications
Work outside EPFL
Journal Articles
Published
Record creation date 2011-09-29

Actions